MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Incorporating Patient and Care Partner Feedback on the Protocol for a Clinical Trial Assessing Progression in MSA

    B. Yang, A. Souza Santana, R. Murphy, C. O’Donnell, M. Jørgensen, L. Kjærsgaard, S. Zanigni (Valby, Denmark)

    Objective: Describe the perspectives of people living with MSA (PwMSA) and their care partners on the design and operational characteristics of a phase 3 trial…
  • 2025 International Congress

    Clinical Characteristics and Antipsychotic Medication Use in Pediatric Population Diagnosed With Tourette Syndrome

    K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Boston, USA)

    Objective: To assess the clinical characteristics and rate of antipsychotic medication discontinuation in a pediatric cohort diagnosed with Tourette syndrome (TS). Background: It is estimated…
  • 2025 International Congress

    Efficacy and Safety of Ecopipam for Tourette Syndrome (TS): Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

    K. Tomczak, S. Atkinson, D. Kim, M. Miller, P. Rice, G. Karkanias, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Chicago, USA)

    Objective: To evaluate the efficacy and safety of ecopipam, a dopamine D1 receptor antagonist, as a maintenance therapy in children, adolescents, and adults with TS.…
  • 2025 International Congress

    Oligodendrocyte-specific mRNA therapy with lipid nanoparticles

    M. Sawamura, K. Tachikawa, R. Hikawa, H. Yamakado, R. Takahashi, S. Matsuzawa (San Diego, USA)

    Objective: To develop lipid nanoparticles with high efficiency and specificity to introduce mRNA into oligodendrocytes. To denmonstrate the potential therapy of Krabbe disease as one…
  • 2025 International Congress

    Functional and Biomechanical characterization through the progression of Parkinson’s Disease

    L. Albarnez, M. San Martín, R. Montefusco (Valdivia, Chile)

    Objective: To describe clinical, electromyographic, and gait kinematic parameters throughout Parkinson’s disease (PD) progression Background: PD is the second most prevalent neurodegenerative disease worldwide. Classic…
  • 2025 International Congress

    Imbalance and falls in individuals with Hereditary Spastic Paraplegia

    G. Dos Santos, M. Severiano, A. Ferraz, C. de Araújo, H. Teive, B. Zeigelboim (Curitiba, Brazil)

    Objective: The aim of this systematic review is to assess imbalance and falls in patients with HSP through a systematic and comprehensive evaluation of the…
  • 2025 International Congress

    Awareness and Implementation of Advanced Care Planning in Patients with Neurodegenerative Diseases

    T. Osada, M. Ohira, K. Kimura, T. Sano, M. Takao (Kodaira, Tokyo, Japan)

    Objective: This study aims to evaluate the awareness and implementation of advanced care planning (ACP) in patients with neurodegenerative diseases in Japan. Background: Although ACP…
  • 2025 International Congress

    Spinocerebellar Ataxia Type 40 (SCA-40) with a Novel Mutation in an Indian Female: A Case Report

    A. Mehta, P. Hiremath, M. Javali, P. R, L. Priya, P. Acharya (Bengaluru, India)

    Objective: To report the first Indian patient with SCA 40 who presented in the fifth decade with a novel missense mutation (c.1291C>T, p.His431Tyr), expanding the…
  • 2025 International Congress

    Refractory Orthostatic Hypotension, Anterocollis Predominant Cervical Dystonia and Parkinsonism Associated with a Previously Undiscovered SYT14 Gene Mutation

    W. Gan, O. Carranza-Renteria, T. Fistel, S. Husain-Wilson (Boca Raton, USA)

    Objective: We present a case of a patient with spinocerebellar ataxia symptoms associated with a previously unknown mutation of the SYT14 gene. Background: Spinocerebellar ataxias…
  • 2025 International Congress

    Hypothalamic Atrophy in CANVAS/RFC1

    C. Lobo, V. Souza, T. Rezende, J. Neiva, P. Matos, F. Lima, A. Martinez, O. Barsottini, J. Pedroso, W. Marques Jr, M. França Jr (Campinas, SP, Brazil)

    Objective: We aimed to investigate hypothalamic volumetry in CANVAS/RFC1. Background: Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is now recognized as a late-onset multisystem…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley